ANI Pharmaceuticals Overview

  • Founded
  • 1996
Founded
  • Status
  • Public
  • Employees
  • 338
Employees
  • Stock Symbol
  • ANIP
Stock Symbol
  • Investments
  • 22
  • Share Price
  • $32.13
  • (As of Friday Closing)

ANI Pharmaceuticals General Information

Description

ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A. It manufactures liquid, powder and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone, and Vancomycin.

Contact Information

Website
www.anipharmaceuticals.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 210 Main Street West
  • Baudette, MN 56623
  • United States
+1 (218) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ANI Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$32.13 $32.10 $23.55 - $68.19 $397M 12.4M 74.4K -$1.99

ANI Pharmaceuticals Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 509,914 872,591 695,461 884,347
Revenue 199,189 206,547 201,576 176,842
EBITDA 12,275 60,735 68,551 56,312
Net Income (23,748) 6,094 15,494 (1,076)
Total Assets 462,581 456,789 430,604 412,138
Total Debt 187,946 185,749 183,015 201,507
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ANI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ANI Pharmaceuticals‘s full profile, request access.

Request a free trial

ANI Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A. It m
Other Healthcare Services
Baudette, MN
338 As of 2019
00000
000000000. 0 00000

0000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
000000000000000
Trevose, PA
000 As of 0000
000000000

0000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
000000000000000
Morristown, NJ
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ANI Pharmaceuticals Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lannett Company Corporation Trevose, PA 000 000000000
0000000 00000 Private Equity-Backed Morristown, NJ 0000 00000 000000000 00000
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0&0
000000 00000000000 Formerly PE-Backed Bridgewater, NJ 0000 00.000 000000 - 000 00.000
000 0000000 0000 0 Formerly PE-Backed Livonia, MI 000 000.00 000000&0 000.00
You’re viewing 5 of 12 competitors. Get the full list »

ANI Pharmaceuticals Executive Team (10)

Name Title Board Seat Contact Info
Nikhil Lalwani Chief Executive Officer & Board Member
Stephen Carey Chief Financial Officer, Finance & Vice President
James Marken Senior Vice President
Robert Schrepfer Senior Vice President
You’re viewing 4 of 10 executive team members. Get the full list »

ANI Pharmaceuticals Board Members (5)

Name Representing Role Since
00000 0000 00 Self Board Member 000 0000
000000 00000 ANI Pharmaceuticals Board Member 000 0000
000000 0000000 ANI Pharmaceuticals Chief Executive Officer & Board Member 000 0000
0000 0000 ANI Pharmaceuticals Board Member 000 0000
To view ANI Pharmaceuticals’s complete board members history, request access »

ANI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ANI Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ANI Pharmaceuticals‘s full profile, request access.

Request a free trial

ANI Pharmaceuticals Investments & Acquisitions (22)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000000000 01-Jul-2020 000000000 00000 00 000 Buildings and Property
00000000 000000000 09-Jan-2020 000000000000000000 000.00 Pharmaceuticals 000000 0000000
0000000 0000000000 18-Jun-2019 000000000 00000 00 000.00 Buildings and Property
0000 0000000000000 01-Mar-2019 000000000 00000 00 00.00 Buildings and Property
Wellspring Pharma Services 06-Aug-2018 Merger/Acquisition 000.00 Other Pharmaceuticals and Biotechnology 000000 0000000
You’re viewing 5 of 22 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial